AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2014
Dec 22, 2014
31523_dirs_2014-12-22_c83e67b2-29a0-465c-8e33-32f54d579fb4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-12-19
Reporting Person: Do Hung (Sr Vice President Discovery)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-19 | Common stock | D | 41441 | $7.88 | Disposed | 953163 | Direct |
Footnotes
F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2014.
F2: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.70 to $8.17. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.